{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-070064","form_type":"8-K","ticker":"EWTX","cik":"0001710072","company_name":"Edgewise Therapeutics, Inc.","filed_at":"2023-06-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.152888+00:00","generated_at":"2026-06-14T03:00:49.810725+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Edgewise Therapeutics shareholders elect three Class II directors, ratify KPMG as auditor at 2023 annual meeting","bullets":["Laura Brege reelected with 47,325,534 votes for, 11,602,125 withheld; broker non-votes 1,064,399.","Badreddin Edris reelected with 45,321,337 for, 13,606,322 withheld; broker non-votes 1,064,399.","Jonathan Root reelected with 45,595,269 for, 13,332,390 withheld; broker non-votes 1,064,399.","Ratification of KPMG as independent auditor passed with 59,989,284 for, 2,555 against, 219 abstain."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-070064","json":"https://secwatch.observer/filing/0001104659-23-070064.json","markdown":"https://secwatch.observer/filing/0001104659-23-070064.md","text":"https://secwatch.observer/filing/0001104659-23-070064.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1710072/000110465923070064/0001104659-23-070064-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1710072/000110465923070064/tm2318406d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T03:00:49.810725+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"88af9195f2bc01c2425c7602992c3854fca49c2a","claim":"Edgewise Therapeutics, Inc. shareholders approved Ratification of the Appointment of Independent Registered Public Accounting Firm at the 2023-06-09 meeting.","evidence_excerpt":"Proposal 2 : Ratification of the Appointment of Independent Registered Public Accounting Firm For Against Abstain 59,989,284 2,555 219 The stockholders ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1710072/000110465923070064/0001104659-23-070064-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-09"}],"fact_type":"shareholder_vote"},{"claim_id":"a636a85e49f41abdaa9b016056f136ceeb961d9c","claim":"Edgewise Therapeutics, Inc. shareholders approved Election of three Class II Directors at the 2023-06-09 meeting.","evidence_excerpt":"Proposal 1: Election of three Class II Directors Name of Director For Withheld Broker Non-Votes Laura Brege 47,325,534 11,602,125 1,064,399 Badreddin Edris, Ph.D. 45,321,337 13,606,322 1,064,399 Jonathan Root, M.D. 45,595,269 13,332,390 1,064,399","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1710072/000110465923070064/0001104659-23-070064-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-09"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}